External medication packaging

- Pfizer Inc.
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top perspective view for an external medication packaging.

FIG. 2 is a back side view thereof;

FIG. 3 is a front side view thereof;

FIG. 4 is a right side view thereof;

FIG. 5 is a left side view thereof;

FIG. 6 is a bottom view thereof;

FIG. 7 is a top view thereof;

FIG. 8 is a top perspective view, shown in an open state; and,

FIG. 9 is a top perspective view thereof, shown with exemplary blister packages.

The broken lines in the drawings represent unclaimed subject matter and form no part of the claim.

The evenly broken lines are shown for the purpose of illustrating environmental subject matter of exemplary blister packages and form no part of the claimed design.

The heavy oval dashed lines shown on the top surface of FIGS. 1, 7, 8 and 9 represent perforations that form part of the claimed design.

Claims

The ornamental design for an external medication packaging, as shown and described.

Referenced Cited
U.S. Patent Documents
D503614 April 5, 2005 Sax
D707552 June 24, 2014 Ahn
D746677 January 5, 2016 Candelaria
D756237 May 17, 2016 Kruse
D842692 March 12, 2019 Breen
D843850 March 26, 2019 LoPrete
D874925 February 11, 2020 Ronge
D904879 December 15, 2020 Lee
Foreign Patent Documents
202009007171 September 2009 DE
2841874 January 2004 FR
216294 January 2023 RU
Other references
  • What is Paxlovid? How it treats COVID and who should take it—YouTube. Date posted: Aug. 2, 2022. Site visited: Apr. 25, 2023. Available online: https://www.youtube.com/watch?v=-VsV2pE5e3U (Year: 2022).
  • “The Perfect Medicalpackaging? Clear, Simple Andtrusty!”, in Packly Blog. Date published: Aug. 4, 2017. Site visited: Apr. 25, 2023. Available online: https://blog.pack.ly/en/medical-packaging-clear-design/ (Year: 2017).
  • “China approves use of Pfi zer's COVID drug Paxlovid,” published in Reuters.com. Date published: Feb. 14, 2022. Site visited: Apr. 25, 2023. Available online: https://www.reuters.com/business/healthcare-pharmaceuticals/china-gives-conditional-approval-pfizers-covid-drug-paxlovid-2022-02-12/ (Year: 2022).
Patent History
Patent number: D1014246
Type: Grant
Filed: Dec 20, 2021
Date of Patent: Feb 13, 2024
Assignee: Pfizer Inc. (New York, NY)
Inventors: Merle Lee (Brentwood, NY), Anthony Mazza (Hasbrouck Heights, NJ), Andrew Ruocco (Morristown, NJ), Kari Peterson (Verona, WI), Hetal Naik (Walton Oaks)
Primary Examiner: Catherine S Posthauer
Assistant Examiner: Joan E. Diehl
Application Number: 29/820,181
Classifications
Current U.S. Class: D9/432